Works matching IS 20457634 AND DT 2022 AND VI 11 AND IP 11

Results: 16

Ixazomib‐based maintenance therapy after bortezomib‐based induction in patients with multiple myeloma not undergoing transplantation: A real‐world study.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2173, doi. 10.1002/cam4.4313

By:

Shen, Man;
Zhang, Jiajia;
Tang, Ran;
Wang, Yuhao;
Zhan, Xiaokai;
Fan, Sibin;
Huang, Zhongxia;
Zhong, Yuping;
Li, Xin

Publication type:

Article

Issue Information.

Published in:: Cancer Medicine, 2022, v. 11, n. 11, p. 2171, doi. 10.1002/cam4.3998
Publication type:: Article

The real‐world clinical outcomes and treatment patterns of patients with unresectable locally advanced or metastatic soft tissue sarcoma treated with anlotinib in the post‐ALTER0203 trial era.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2271, doi. 10.1002/cam4.4613

By:

Zhang, Ren‐Shu;
Liu, Jie;
Deng, Yao‐Tiao;
Wu, Xin;
Jiang, Yu

Publication type:

Article

Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: A population‐based study.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2308, doi. 10.1002/cam4.4614

By:

Zhan, Xiangpeng;
Chen, Luyao;
Jiang, Ming;
Fu, Bin

Publication type:

Article

Effect of modified no‐touch laparoscopic radical hysterectomy on outcomes of early stage cervical cancer: A retrospective cohort study.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2224, doi. 10.1002/cam4.4612

By:

He, Fangjie;
Yuan, Songhua;
Chen, Xia;
Zhang, Siyou;
Han, Yubin;
Lin, Tiecheng;
Xu, Bingnan;
Huang, Shimin;
Pan, Zhiyin

Publication type:

Article

Carcinosarcoma is an aggressive subtype of bladder cancer: A population‐based study.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2216, doi. 10.1002/cam4.4611

By:

Liu, Lin;
Zhu, Jinglan;
Tian, Yun

Publication type:

Article

Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2296, doi. 10.1002/cam4.4610

By:

Lu, Zhanni;
Zhang, Ning;
Giordano, Sharon H.;
Zhao, Hui

Publication type:

Article

Surgical site infection following minimally invasive lobectomy: Is robotic surgery superior?

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2233, doi. 10.1002/cam4.4609

By:

Hou, Yucheng;
Hu, Yeyan;
Song, Weijian;
Zhang, Jianfeng;
Luo, Qingquan;
Zhou, Qianjun

Publication type:

Article

Rural–urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2284, doi. 10.1002/cam4.4605

By:

Riley, Danielle;
Chrischilles, Elizabeth A.;
Lizarraga, Ingrid M.;
Charlton, Mary;
Smith, Brian J.;
Lynch, Charles F.

Publication type:

Article

COVID‐19 outcomes in patients with cancer: Findings from the University of California health system database.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2204, doi. 10.1002/cam4.4604

By:

Kwon, Daniel H.;
Cadena, Jose;
Nguyen, Sam;
Chan, Kwan Ho Ryan;
Soper, Braden;
Gryshuk, Amy L.;
Hong, Julian C.;
Ray, Priyadip;
Huang, Franklin W.

Publication type:

Article

Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment‐naïve patients: A single‐center study.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2193, doi. 10.1002/cam4.4600

By:

Nikas, Ilias P.;
Lee, Cheol;
Song, Min Ji;
Kim, Bohyun;
Ryu, Han Suk

Publication type:

Article

The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2184, doi. 10.1002/cam4.4599

By:

Kawakami, Takeshi;
Masuishi, Toshiki;
Kawamoto, Yasuyuki;
Go, Hirofumi;
Kato, Kyoko;
Kumanishi, Ryosuke;
Sawada, Kentaro;
Yuki, Satoshi;
Yamamoto, Kouji;
Komatsu, Yoshito;
Muro, Kei;
Fushiki, Kunihiro;
Shirasu, Hiromichi;
Yamazaki, Kentaro

Publication type:

Article

A novel signature based on immune‐related gene pairs and clinical features to predict prognosis and treatment effect in "driver gene negative" lung adenocarcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2259, doi. 10.1002/cam4.4577

By:

Cai, He‐yuan;
Yang, Hao‐shuai;
Shan, Shi‐chao;
Lei, Yi‐yan;
Zou, Jian‐yong;
Zhu, Ying;
Luo, Hong‐he

Publication type:

Article

Development and validation of an immune‐related prognosis signature associated with hypoxia and ferroptosis in hepatocellular carcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2329, doi. 10.1002/cam4.4556

By:

Yang, Chun‐Bo;
Feng, Han‐Xin;
Dai, Chao‐Liu

Publication type:

Article

Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2244, doi. 10.1002/cam4.4547

By:

Liang, Jiaqi;
Chen, Zhencong;
Huang, Yiwei;
Bi, Guoshu;
Bian, Yunyi;
Jin, Xing;
Zhang, Huan;
Sui, Qihai;
Zhan, Cheng;
Wang, Qun

Publication type:

Article

Primary and mental health service use in community health center patients before and after cancer diagnosis.

Published in:

Cancer Medicine, 2022, v. 11, n. 11, p. 2320, doi. 10.1002/cam4.4524

By:

Larson, Annie E.;
Angier, Heather;
Suchocki, Andrew;
Voss, Robert W.;
Marino, Miguel;
Warren, Nathaniel;
Huguet, Nathalie

Publication type:

Article